Levoleucovorin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Levoleucovorin drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Levoleucovorin |
SUBSTANCE NAME: | LEVOLEUCOVORIN CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-02-06 |
END MARKETING DATE: | 0000-00-00 |
Levoleucovorin HUMAN PRESCRIPTION DRUG Details:
Item Description | Levoleucovorin from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2017-02-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-4130_e681ee9e-e794-45e9-8033-5fc913efbb2a |
PRODUCT NDC: | 0591-4130 |
APPLICATION NUMBER: | NDA208723 |
Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers: